Key result
Inhibitors of the renin-angiotensin system are evaluated to determine whether they should be withdrawn in patients with COVID-19.
Authors
Loading...
Key points are not available for this paper at this time.
Kuster et al. (2020) studied this question. Inhibitors of the renin-angiotensin system are evaluated to determine whether they should be withdrawn in patients with COVID-19.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: